Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
85.50
+0.07 (0.08%)
Nov 20, 2024, 4:00 PM EST - Market closed
Alcon Revenue
Alcon had revenue of $2.45B in the quarter ending September 30, 2024, with 5.37% growth. This brings the company's revenue in the last twelve months to $9.76B, up 5.25% year-over-year. In the year 2023, Alcon had annual revenue of $9.46B with 8.47% growth.
Revenue (ttm)
$9.76B
Revenue Growth
+5.25%
P/S Ratio
n/a
Revenue / Employee
$385,582
Employees
25,315
Market Cap
42.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9.46B | 738.00M | 8.47% |
| Dec 31, 2022 | 8.72B | 426.00M | 5.14% |
| Dec 31, 2021 | 8.29B | 1.46B | 21.34% |
| Dec 31, 2020 | 6.83B | -675.00M | -8.99% |
| Dec 31, 2019 | 7.51B | 355.00M | 4.96% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 367.25B |
| Cencora | 293.96B |
| GSK | 41.97B |
| Takeda Pharmaceutical | 31.73B |
| Becton, Dickinson and Company | 19.83B |
| GE HealthCare Technologies | 19.56B |
| Haleon | 15.07B |
| Agilent Technologies | 6.50B |
ALC News
- 7 days ago - Alcon: Q3, Slight Guidance Cut Is Not Something Structural - Seeking Alpha
- 7 days ago - Alcon (ALC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Alcon cuts 2024 forecasts, as slow US hits surgical unit - Reuters
- 8 days ago - Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation - Business Wire
- 3 months ago - Alcon Analysts Increase Their Forecasts After Q2 Results - Benzinga
- 3 months ago - Alcon Inc. (ALC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses - Business Wire
- 5 months ago - Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance - Business Wire